An Integrative Human Pan-Cancer Analysis of Cyclin-Dependent Kinase 1 (CDK1)
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An Integrative Human Pan-Cancer Analysis of Cyclin-Dependent Kinase 1 (CDK1)
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 11, Pages 2658
Publisher
MDPI AG
Online
2022-05-27
DOI
10.3390/cancers14112658
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cell Cycle-Dependent Transcription: The Cyclin Dependent Kinase Cdk1 Is a Direct Regulator of Basal Transcription Machineries
- (2022) Jorrit M. Enserink et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immune Checkpoint Gene Expression Profiling Identifies Programmed Cell Death Ligand-1 Centered Immunologic Subtypes of Oral and Squamous Cell Carcinoma With Favorable Survival
- (2022) Yang Yu et al. Frontiers in Medicine
- Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1–AKT pathway
- (2022) Han-Ming Huang et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Upregulation of KIF11 in TP53 Mutant Glioma Promotes Tumor Stemness and Drug Resistance
- (2021) Bin Liu et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- KIF11 Promotes Proliferation of Hepatocellular Carcinoma among Patients with Liver Cancers
- (2021) Zhan-Dong Hu et al. Biomed Research International
- Cyclin A2/Cdk1-dependent phosphorylation of Top2a is required for S phase entry during retinal development in zebrafish
- (2021) Miaomiao Jin et al. Journal of Genetics and Genomics
- PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer
- (2021) Alessandro Rizzo et al. Cancers
- Integrated Protein–Protein Interaction and Weighted Gene Co-expression Network Analysis Uncover Three Key Genes in Hepatoblastoma
- (2021) Linlin Tian et al. Frontiers in Cell and Developmental Biology
- Phosphoproteome Profiling Revealed the Importance of mTOR Inhibition on CDK1 Activation to Further Regulate Cell Cycle Progression
- (2021) Luqi Jin et al. JOURNAL OF PROTEOME RESEARCH
- Cell cycle control in cancer
- (2021) Helen K. Matthews et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Metabolic Interdependency of Th2 Cell-Mediated Type 2 Immunity and the Tumor Microenvironment
- (2021) Simon Schreiber et al. Frontiers in Immunology
- Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC)
- (2021) Rosa Wijnen et al. Cancers
- CancerSCEM: a database of single-cell expression map across various human cancers
- (2021) Jingyao Zeng et al. NUCLEIC ACIDS RESEARCH
- Bioinformatic Evidence Reveals that Cell Cycle Correlated Genes Drive the Communication between Tumor Cells and the Tumor Microenvironment and Impact the Outcomes of Hepatocellular Carcinoma
- (2021) Dongdong Chen et al. Biomed Research International
- Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers
- (2021) M. Palmeri et al. ESMO Open
- CDK1 couples proliferation with protein synthesis
- (2020) Katharina Haneke et al. JOURNAL OF CELL BIOLOGY
- Pan-cancer analysis of whole genomes
- (2020) NATURE
- CDK1 dependent phosphorylation of hTERT contributes to cancer progression
- (2020) Mami Yasukawa et al. Nature Communications
- mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
- (2020) Zhilin Zou et al. Cell and Bioscience
- Role of Cyclin-Dependent Kinase 1 in Translational Regulation in the M-Phase
- (2020) Jaroslav Kalous et al. Cells
- The tumor microenvironment
- (2020) Nicole M. Anderson et al. CURRENT BIOLOGY
- CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer
- (2020) Jin Huang et al. GUT
- Data mining combined with experiments to validate CEP55 as a prognostic biomarker in colorectal cancer
- (2020) Kang Lin et al. Immunity Inflammation and Disease
- Mitotic slippage: an old tale with a new twist
- (2019) Debottam Sinha et al. CELL CYCLE
- Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma
- (2019) Shu Dong et al. BIOSCIENCE REPORTS
- GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
- (2019) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- High expression of CDK1 and BUB1 predicts poor prognosis of pancreatic ductal adenocarcinoma
- (2019) Junjie Piao et al. GENE
- Combination of CTLA-4 and PD-1 blockers for treatment of cancer
- (2019) Anand Rotte JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis
- (2019) Jinbeom Heo et al. EMBO Molecular Medicine
- Targeting the KIF4A/AR Axis to Reverse Endocrine Therapy Resistance in Castration-resistant Prostate Cancer
- (2019) Qi Cao et al. CLINICAL CANCER RESEARCH
- Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers
- (2019) Fengju Chen et al. Nature Communications
- Myc stimulates cell cycle progression through the activation of Cdk1 and phosphorylation of p27
- (2019) Lucía García-Gutiérrez et al. Scientific Reports
- Mechanisms of resistance to immune checkpoint inhibitors
- (2018) Russell W Jenkins et al. BRITISH JOURNAL OF CANCER
- An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
- (2018) Jianfang Liu et al. CELL
- Overexpression of Zwint predicts poor prognosis and promotes the proliferation of hepatocellular carcinoma by regulating cell-cycle-related proteins
- (2018) Hanning Ying et al. OncoTargets and Therapy
- Upregulation of kinesin family member 4A enhanced cell proliferation via activation of Akt signaling and predicted a poor prognosis in hepatocellular carcinoma
- (2018) Yanlin Huang et al. Cell Death & Disease
- Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma
- (2018) Chuan Xing Wu et al. Theranostics
- CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer
- (2018) Murugan Kalimutho et al. EMBO Molecular Medicine
- CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma
- (2018) Dinoop Ravindran Menon et al. CANCER RESEARCH
- Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs
- (2018) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Cdk1-dependent phosphorylation of KIF4A at S1186 triggers lateral chromosome compaction during early mitosis
- (2018) Hideaki Takata et al. PLoS One
- MDSC; the Most Important Cell You Have Never Heard Of
- (2018) R.J. Tesi TRENDS IN PHARMACOLOGICAL SCIENCES
- Cyclin B1/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance
- (2018) Bowen Xie et al. CANCER LETTERS
- Targeting CDK1 and MEK/ERK Overcomes Apoptotic Resistance in BRAF-Mutant Human Colorectal Cancer
- (2017) Peng Zhang et al. MOLECULAR CANCER RESEARCH
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cyclin A2 is an RNA binding protein that controls Mre11 mRNA translation
- (2016) A. Kanakkanthara et al. SCIENCE
- Restoration of paclitaxel resistance by CDK1 intervention in drug-resistant ovarian cancer
- (2015) Taejeong Bae et al. CARCINOGENESIS
- Zwint-1 is required for spindle assembly checkpoint function and kinetochore-microtubule attachment during oocyte meiosis
- (2015) Dong Woo Seo et al. Scientific Reports
- jvenn: an interactive Venn diagram viewer
- (2014) Philippe Bardou et al. BMC BIOINFORMATICS
- Loss of Cdk2 and Cyclin A2 Impairs Cell Proliferation and Tumorigenesis
- (2014) L. Gopinathan et al. CANCER RESEARCH
- Cyclin-dependent kinases
- (2014) Marcos Malumbres GENOME BIOLOGY
- GSVA: gene set variation analysis for microarray and RNA-Seq data
- (2013) Sonja Hänzelmann et al. BMC BIOINFORMATICS
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
- (2013) Gabriela Bindea et al. IMMUNITY
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- MYC on the Path to Cancer
- (2012) Chi V. Dang CELL
- Increased Myeloid-Derived Suppressor Cells in Gastric Cancer Correlate with Cancer Stage and Plasma S100A8/A9 Proinflammatory Proteins
- (2012) L. Wang et al. JOURNAL OF IMMUNOLOGY
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
- (2012) Guangchuang Yu et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration
- (2012) M. K. Diril et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An overview of Cdk1-controlled targets and processes
- (2010) Jorrit M Enserink et al. Cell Division
- A Mitotic Phosphorylation Feedback Network Connects Cdk1, Plk1, 53BP1, and Chk2 to Inactivate the G2/M DNA Damage Checkpoint
- (2010) Marcel A. T. M. van Vugt et al. PLOS BIOLOGY
- Cyclin A-Cdk1 regulates the origin firing program in mammalian cells
- (2009) Y. Katsuno et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now